The rate, risk factors, and outcome of fungal peritonitis in CAPD patients: experience in Turkey.
Taşkapan
H
H
Ozener
C
C
Ateş
K
K
Akçiçek
F
F
Yavuz
M
M
Yilmaz
M E
ME
Ataman
R
R
Bozfakioglu
S
S
Camsari
T
T
Ersoy
F F
FF
Karayaylali
I
I
Akpolat
T
T
Utaş
C
C
D000328:Adult; D017677:Age Distribution; D000368:Aged; D000369:Aged, 80 and over; D000935:Antifungal Agents / Q000627:therapeutic use; D005260:Female; D006801:Humans; D015994:Incidence; D007676:Kidney Failure, Chronic / Q000628:therapy; D008297:Male; D008875:Middle Aged; D009181:Mycoses / Q000188:drug therapy / Q000453:epidemiology*; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000009:adverse effects* / Q000379:methods; D010538:Peritonitis / Q000188:drug therapy / Q000453:epidemiology* / Q000382:microbiology; D012189:Retrospective Studies; D012307:Risk Factors; D017678:Sex Distribution; D016896:Treatment Outcome; D014421:Turkey / Q000453:epidemiology
D000935:Antifungal Agents